Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 307 Lung Neoplasms 111 Pancreatic Neoplasms 70 Neoplasms 56 Neoplasm Metastasis 32 Brain Neoplasms 31 Head and Neck Neoplasms 26 Squamous Cell Carcinoma of Head and Neck 25 Breast Neoplasms 25 Glioblastoma 24 Adenocarcinoma of Lung 23 Gliosarcoma 22 Non-Squamous Non-Small Cell Lung Cancer 21 Colorectal Neoplasms 18 Carcinoma, Hepatocellular 17 Adenocarcinoma, Bronchiolo-Alveolar 16 Rectal Neoplasms 13 Colonic Neoplasms 13 Carcinoma, Renal Cell 13 Glioma 12 Esophageal Neoplasms 11 Astrocytoma 11 Central Nervous System Neoplasms 9 Carcinoma, Squamous Cell 9 Salivary Gland Neoplasms 8 Prostatic Neoplasms 8 Oligodendroglioma 8 Gallbladder Neoplasms 8 Adenocarcinoma 8 Ovarian Neoplasms 7

Interventions

Gemcitabine 13 Albumin-Bound Paclitaxel 8 Taxes 6 130-nm albumin-bound paclitaxel 6 Fluorouracil 5 Oxaliplatin 4 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Leucovorin 3 Irinotecan 3 Losartan 2 Cisplatin 2 tocilizumab 1 selicrelumab 1 niraparib 1 irinotecan sucrosofate 1 indusatumab 1 folfirinox 1 durvalumab 1 cobimetinib 1 atezolizumab 1 X-Rays 1 Tiragolumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Adenocarcinoma × Erlotinib Hydrochloride × Clear all

NCT01389440 2018-05-18

GEMCAD1003

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Completed

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡